- Report
- October 2024
- 193 Pages
Global
From €3370EUR$3,545USD£2,831GBP
€3745EUR$3,939USD£3,146GBP
- Report
- February 2025
- 100 Pages
Global
From €5656EUR$5,950USD£4,752GBP
- Report
- March 2025
- 189 Pages
Global
From €4706EUR$4,950USD£3,953GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1901EUR$2,000USD£1,597GBP
- Report
- September 2024
- 156 Pages
Global
From €2377EUR$2,500USD£1,997GBP
- Report
- February 2025
- 200 Pages
Global
From €4268EUR$4,490USD£3,586GBP
- Report
- June 2024
- 200 Pages
Global
From €7558EUR$7,950USD£6,349GBP
- Drug Pipelines
- April 2024
- 60 Pages
Global
From €1901EUR$2,000USD£1,597GBP
- Report
- February 2025
- 200 Pages
Global
From €4268EUR$4,490USD£3,586GBP
- Report
- July 2024
- 180 Pages
Global
From €2377EUR$2,500USD£1,997GBP
- Report
- January 2025
- 144 Pages
Global
From €3755EUR$3,950USD£3,155GBP
- Report
- February 2025
- 181 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Report
- August 2024
- 164 Pages
Global
From €4749EUR$4,995USD£3,989GBP
- Report
- May 2021
- 177 Pages
United States
€1421EUR$1,495USD£1,194GBP
- Report
- February 2023
- 152 Pages
Global
From €2377EUR$2,500USD£1,997GBP
- Report
- January 2024
- 150 Pages
Global
From €4611EUR$4,850USD£3,873GBP
- Report
- March 2024
- 143 Pages
Global
From €2851EUR$2,999USD£2,395GBP
- Report
- February 2024
- 120 Pages
Asia Pacific
From €4706EUR$4,950USD£3,953GBP
- Report
- January 2022
- 60 Pages
Global
From €3755EUR$3,950USD£3,155GBP
- Report
- October 2022
- 119 Pages
Global
From €4278EUR$4,500USD£3,594GBP

The Insomnia Drug market is a subset of the Central Nervous System Drugs market, which includes drugs used to treat neurological disorders. Insomnia drugs are used to treat difficulty sleeping, and can be divided into two categories: sedative-hypnotics and non-sedative hypnotics. Sedative-hypnotics are drugs that act on the central nervous system to induce sleep, while non-sedative hypnotics are drugs that act on the brain to improve sleep quality without causing sedation. Commonly prescribed insomnia drugs include benzodiazepines, non-benzodiazepines, and melatonin receptor agonists.
Some companies in the Insomnia Drug market include Sanofi, Pfizer, Merck, GlaxoSmithKline, and Takeda. Show Less Read more